Dr Wu Skincare Co Ltd (達爾膚生醫科技) yesterday reported revenue of NT$78.16 million (US$2.51 million) last month, down 18.09 percent from NT$95.42 million a year earlier.
The firm blamed the decline on slow seasonal demand and business strategy adjustments that include a decrease in promotional sales.
Nonetheless, Dr Wu reported that second-quarter revenue rose 9.62 percent year-on-year to NT$254.34 million thanks to the launch of new products and Mother’s Day sales.
The company reported that cumulative revenue from January to June increased 14.86 percent to NT$512.65 million thanks to strong sales in Taiwan and China.
Brick-and-mortar sales in Taiwan increased by 15 percent in the first half of the year, while online sales in China increased by 25 percent, the company said in a statement.
Taiwan remains the biggest sales region for the company, contributing up to 70 percent of total revenue, chief financial officer Monica Wu (王郁婷) told the Taipei Times by telephone, adding that the Chinese sales region contributes another 25 to 30 percent.
Sales in China are expected to increase in the coming months and to become the company’s main growth driver, Dr Wu said, citing a report published by the Chinese market research firm ASKCI Consulting Co (中商產業研究院).
Dr Wu said that it is looking to further strengthen its brand presence in the Chinese market through e-commerce platforms, while increasing offline distribution of its products through professional dealers.
Three experts in the high technology industry have said that US President Donald Trump’s pledge to impose higher tariffs on Taiwanese semiconductors is part of an effort to force Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) to the negotiating table. In a speech to Republicans on Jan. 27, Trump said he intends to impose tariffs on Taiwan to bring chip production to the US. “The incentive is going to be they’re not going to want to pay a 25, 50 or even a 100 percent tax,” he said. Darson Chiu (邱達生), an economics professor at Taichung-based Tunghai University and director-general of
Zhang Yazhou was sitting in the passenger seat of her Tesla Model 3 when she said she heard her father’s panicked voice: The brakes do not work. Approaching a red light, her father swerved around two cars before plowing into a sport utility vehicle and a sedan, and crashing into a large concrete barrier. Stunned, Zhang gazed at the deflating airbag in front of her. She could never have imagined what was to come: Tesla Inc sued her for defamation for complaining publicly about the vehicles brakes — and won. A Chinese court ordered Zhang to pay more than US$23,000 in
‘LEGACY CHIPS’: Chinese companies have dramatically increased mature chip production capacity, but the West’s drive for secure supply chains offers a lifeline for Taiwan When Powerchip Technology Corp (力晶科技) entered a deal with the eastern Chinese city of Hefei in 2015 to set up a new chip foundry, it hoped the move would help provide better access to the promising Chinese market. However, nine years later, that Chinese foundry, Nexchip Semiconductor Corp (合晶集成), has become one of its biggest rivals in the legacy chip space, leveraging steep discounts after Beijing’s localization call forced Powerchip to give up the once-lucrative business making integrated circuits for Chinese flat panels. Nexchip is among Chinese foundries quickly winning market share in the crucial US$56.3 billion industry of so-called legacy
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday held its first board of directors meeting in the US, at which it did not unveil any new US investments despite mounting tariff threats from US President Donald Trump. Trump has threatened to impose 100 percent tariffs on Taiwan-made chips, prompting market speculation that TSMC might consider boosting its chip capacity in the US or ramping up production of advanced chips such as those using a 2-nanometer technology process at its Arizona fabs ahead of schedule. Speculation also swirled that the chipmaker might consider building its own advanced packaging capacity in the US as part